Creating a treatment for a rare disease is difficult. Almost as difficult as finding an agency that gets you. When one‑size‑fits‑all doesn't cut it, we understand the importance of a tailored approach in rare disease, going beyond to truly comprehend the clinical issues facing stakeholders. It's why we're also dedicated to learning your brand inside and out, delivering bespoke creative built on strategy and one‑of‑a‑kind precision, purpose and passion.
Duchenne Muscular Distrophy (DMD)
Idiopathic Pulmonary Fibrosis (IPF)
Respiratory dysfunction in DMD
Hereditary Angioedema (HAE)
Thyroid Eye Disease (TED)
Leber's Hereditary Optic Neuropathy (LHON)
NTRK Fusion Positive Tumours
Hereditary ATTR Amyloidosis
Vernal Keratoconjuntivities (VKC)
AADC Deficiency (Aromatic l‑amino acid decarboxylase)
Giant Cell Arteritis (GCA)
Systemic Juvenile Idiopathic Arthritis (sJIA)
Polyarticular Juvenile Idiopathic Arthritis (pJIA)